Industry Research Reports
Home > Reports > Chemical & Material > Global Dehydroepiandrosterone (DHEA) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Dehydroepiandrosterone (DHEA) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Chemical & Material
Published Date: 2026-03-09
Pages: 78 Pages
Report ld: 6050635
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Dehydroepiandrosterone (DHEA) Market Size(US$)
CAGR 2026-2032
7.1%
Market Size,2032
USD 81.63
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 54.21 million
Market Forecast in 2032(Value)
US$ 81.63 million
CAGR
7.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Dehydroepiandrosterone (DHEA) market size was US$ 50.97 million in 2025 and is forecast to reach a readjusted size of US$ 81.63 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Dehydroepiandrosterone (DHEA), also known as androstenolone, is an endogenous steroid hormone precursor. It is one of the most abundant circulating steroids in humans. DHEA is produced in the adrenal glands, the gonads, and the brain. It functions as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids both in the gonads and in various other tissues. However, DHEA also has a variety of potential biological effects in its own right, binding to an array of nuclear and cell surface receptors, and acting as a neurosteroid and modulator of neurotrophic factor receptors.
Research institutions and pharmaceutical companies are exploring prasterone's potential beyond its current uses, including neuroprotection and metabolic modulation, potentially broadening its market scope. In developed regions like the U.S. and Europe, prasterone is increasingly seen as part of the growing hormone replacement therapy market, driven by an aging population seeking to address not only physical but also sexual and cognitive health declines. As DHEA levels naturally decrease after age 30—particularly rapidly in women—the need for hormonal balance interventions has grown, making prasterone-based therapies more appealing. Additionally, a broader wellness trend focusing on holistic health and quality of life improvements has positioned prasterone as a non-traditional yet scientifically backed option. Significant investments in research by both academia and industry have accelerated the understanding of prasterone's multifaceted benefits, supporting its development as a safer alternative for hormone replacement. Simultaneously, the facial mask market is expanding due to increased skincare awareness among younger generations and the influence of strong skincare cultures in South Korea, Japan, and China. The rise of online sales channels, live streaming, and influencer marketing has amplified brand reach, especially among younger, trend-driven consumers. Men are increasingly embracing skincare, expanding the consumer base, particularly in China. Brands are developing masks tailored to specific skin concerns, incorporating ingredients like sodium hyaluronate and collagen, while also exploring sustainable, eco-friendly materials. Multifunctional masks that combine benefits like anti-aging, hydration, and brightening are becoming popular among busy consumers seeking effective, convenient solutions.
The global Dehydroepiandrosterone (DHEA) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- Yicheng Goto Pharmaceuticals Co.,Ltd.
- Junye Pharmaceutical Co., Ltd.
- Zhejiang Shenzhou Pharmaceutical Co., Ltd.
- Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
- Jiangsu Jiaerke Pharmaceuticals Group Corp.
- Wudang Antai Pharmaceutical Co., Ltd.
- Shandong Saito Biotechnology Co., Ltd.
- Hubei Dan'ao Pharmaceutical Co., Ltd.
- Symbiotec Pharma Lab Pvt. Ltd.
- NutriScience Innovations, LLC
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- ≥ 99％
- Others
Segment by Application
- Medicine
- Dietary Supplements
- Skin Care Products
- Reagents
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Dehydroepiandrosterone (DHEA) sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Dehydroepiandrosterone (DHEA) manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Dehydroepiandrosterone (DHEA) product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Dehydroepiandrosterone (DHEA) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dehydroepiandrosterone (DHEA) Product Scope
1.2 Dehydroepiandrosterone (DHEA) by Type
1.2.1 Global Dehydroepiandrosterone (DHEA) Sales by Type (2021, 2025 & 2032)
1.2.2 ≥ 99％
1.2.3 Others
1.3 Dehydroepiandrosterone (DHEA) by Application
1.3.1 Global Dehydroepiandrosterone (DHEA) Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Medicine
1.3.3 Dietary Supplements
1.3.4 Skin Care Products
1.3.5 Reagents
1.3.6 Others
1.4 Global Dehydroepiandrosterone (DHEA) Market Estimates and Forecasts (2021-2032)
1.4.1 Global Dehydroepiandrosterone (DHEA) Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Dehydroepiandrosterone (DHEA) Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Dehydroepiandrosterone (DHEA) Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Dehydroepiandrosterone (DHEA) Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Dehydroepiandrosterone (DHEA) Historical Market Scenario by Region (2021-2026)
2.2.1 Global Dehydroepiandrosterone (DHEA) Sales Market Share by Region (2021-2026)
2.2.2 Global Dehydroepiandrosterone (DHEA) Revenue Market Share by Region (2021-2026)
2.3 Global Dehydroepiandrosterone (DHEA) Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Dehydroepiandrosterone (DHEA) Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Dehydroepiandrosterone (DHEA) Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Dehydroepiandrosterone (DHEA) Market Size and Prospects (2021-2032)
2.4.2 Europe Dehydroepiandrosterone (DHEA) Market Size and Prospects (2021-2032)
2.4.3 China Dehydroepiandrosterone (DHEA) Market Size and Prospects (2021-2032)
2.4.4 Japan Dehydroepiandrosterone (DHEA) Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Dehydroepiandrosterone (DHEA) Historical Market Review by Type (2021-2026)
3.1.1 Global Dehydroepiandrosterone (DHEA) Sales by Type (2021-2026)
3.1.2 Global Dehydroepiandrosterone (DHEA) Revenue by Type (2021-2026)
3.1.3 Global Dehydroepiandrosterone (DHEA) Average Price by Type (2021-2026)
3.2 Global Dehydroepiandrosterone (DHEA) Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Dehydroepiandrosterone (DHEA) Sales Forecast by Type (2027-2032)
3.2.2 Global Dehydroepiandrosterone (DHEA) Revenue Forecast by Type (2027-2032)
3.2.3 Global Dehydroepiandrosterone (DHEA) Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Dehydroepiandrosterone (DHEA)
4 Global Market Size by Application
4.1 Global Dehydroepiandrosterone (DHEA) Historical Market Review by Application (2021-2026)
4.1.1 Global Dehydroepiandrosterone (DHEA) Sales by Application (2021-2026)
4.1.2 Global Dehydroepiandrosterone (DHEA) Revenue by Application (2021-2026)
4.1.3 Global Dehydroepiandrosterone (DHEA) Average Price by Application (2021-2026)
4.2 Global Dehydroepiandrosterone (DHEA) Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Dehydroepiandrosterone (DHEA) Sales Forecast by Application (2027-2032)
4.2.2 Global Dehydroepiandrosterone (DHEA) Revenue Forecast by Application (2027-2032)
4.2.3 Global Dehydroepiandrosterone (DHEA) Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Dehydroepiandrosterone (DHEA) Applications
5 Competition Landscape by Players
5.1 Global Dehydroepiandrosterone (DHEA) Sales by Player (2021-2026)
5.2 Global Top Dehydroepiandrosterone (DHEA) Players by Revenue (2021-2026)
5.3 Global Dehydroepiandrosterone (DHEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Dehydroepiandrosterone (DHEA) revenue as of 2025
5.4 Global Dehydroepiandrosterone (DHEA) Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Product Type & Application
5.7 Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Dehydroepiandrosterone (DHEA) Sales by Company
6.1.1.1 North America Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026)
6.1.1.2 North America Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026)
6.1.2 North America Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2021-2026)
6.1.3 North America Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2021-2026)
6.1.4 North America Dehydroepiandrosterone (DHEA) Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Dehydroepiandrosterone (DHEA) Sales by Company
6.2.1.1 Europe Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026)
6.2.1.2 Europe Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026)
6.2.2 Europe Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2021-2026)
6.2.3 Europe Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2021-2026)
6.2.4 Europe Dehydroepiandrosterone (DHEA) Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Dehydroepiandrosterone (DHEA) Sales by Company
6.3.1.1 China Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026)
6.3.1.2 China Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026)
6.3.2 China Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2021-2026)
6.3.3 China Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2021-2026)
6.3.4 China Dehydroepiandrosterone (DHEA) Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Dehydroepiandrosterone (DHEA) Sales by Company
6.4.1.1 Japan Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026)
6.4.1.2 Japan Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026)
6.4.2 Japan Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2021-2026)
6.4.3 Japan Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2021-2026)
6.4.4 Japan Dehydroepiandrosterone (DHEA) Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Yicheng Goto Pharmaceuticals Co.,Ltd.
7.1.1 Yicheng Goto Pharmaceuticals Co.,Ltd. Company Information
7.1.2 Yicheng Goto Pharmaceuticals Co.,Ltd. Business Overview
7.1.3 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.1.5 Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Development
7.2 Junye Pharmaceutical Co., Ltd.
7.2.1 Junye Pharmaceutical Co., Ltd. Company Information
7.2.2 Junye Pharmaceutical Co., Ltd. Business Overview
7.2.3 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.2.5 Junye Pharmaceutical Co., Ltd. Recent Development
7.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd.
7.3.1 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Company Information
7.3.2 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Business Overview
7.3.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.3.5 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Development
7.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
7.4.1 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Company Information
7.4.2 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Business Overview
7.4.3 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.4.5 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Development
7.5 Jiangsu Jiaerke Pharmaceuticals Group Corp.
7.5.1 Jiangsu Jiaerke Pharmaceuticals Group Corp. Company Information
7.5.2 Jiangsu Jiaerke Pharmaceuticals Group Corp. Business Overview
7.5.3 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Products Offered
7.5.5 Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Development
7.6 Wudang Antai Pharmaceutical Co., Ltd.
7.6.1 Wudang Antai Pharmaceutical Co., Ltd. Company Information
7.6.2 Wudang Antai Pharmaceutical Co., Ltd. Business Overview
7.6.3 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.6.5 Wudang Antai Pharmaceutical Co., Ltd. Recent Development
7.7 Shandong Saito Biotechnology Co., Ltd.
7.7.1 Shandong Saito Biotechnology Co., Ltd. Company Information
7.7.2 Shandong Saito Biotechnology Co., Ltd. Business Overview
7.7.3 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.7.5 Shandong Saito Biotechnology Co., Ltd. Recent Development
7.8 Hubei Dan'ao Pharmaceutical Co., Ltd.
7.8.1 Hubei Dan'ao Pharmaceutical Co., Ltd. Company Information
7.8.2 Hubei Dan'ao Pharmaceutical Co., Ltd. Business Overview
7.8.3 Hubei Dan'ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Hubei Dan'ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.8.5 Hubei Dan'ao Pharmaceutical Co., Ltd. Recent Development
7.9 Symbiotec Pharma Lab Pvt. Ltd.
7.9.1 Symbiotec Pharma Lab Pvt. Ltd. Company Information
7.9.2 Symbiotec Pharma Lab Pvt. Ltd. Business Overview
7.9.3 Symbiotec Pharma Lab Pvt. Ltd. Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Symbiotec Pharma Lab Pvt. Ltd. Dehydroepiandrosterone (DHEA) Products Offered
7.9.5 Symbiotec Pharma Lab Pvt. Ltd. Recent Development
7.10 NutriScience Innovations, LLC
7.10.1 NutriScience Innovations, LLC Company Information
7.10.2 NutriScience Innovations, LLC Business Overview
7.10.3 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2021-2026)
7.10.4 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Products Offered
7.10.5 NutriScience Innovations, LLC Recent Development
8 Dehydroepiandrosterone (DHEA) Manufacturing Cost Analysis
8.1 Dehydroepiandrosterone (DHEA) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Dehydroepiandrosterone (DHEA)
8.4 Dehydroepiandrosterone (DHEA) Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Dehydroepiandrosterone (DHEA) Distributors List
9.3 Dehydroepiandrosterone (DHEA) Customers
10 Dehydroepiandrosterone (DHEA) Market Dynamics
10.1 Dehydroepiandrosterone (DHEA) Industry Trends
10.2 Dehydroepiandrosterone (DHEA) Market Drivers
10.3 Dehydroepiandrosterone (DHEA) Market Challenges
10.4 Dehydroepiandrosterone (DHEA) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Dehydroepiandrosterone (DHEA) Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Dehydroepiandrosterone (DHEA) Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Dehydroepiandrosterone (DHEA) Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Dehydroepiandrosterone (DHEA) Sales (kg) by Region (2021-2026)
Table 5. Global Dehydroepiandrosterone (DHEA) Sales Market Share by Region (2021-2026)
Table 6. Global Dehydroepiandrosterone (DHEA) Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Dehydroepiandrosterone (DHEA) Revenue Share by Region (2021-2026)
Table 8. Global Dehydroepiandrosterone (DHEA) Sales (kg) Forecast by Region (2027-2032)
Table 9. Global Dehydroepiandrosterone (DHEA) Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Dehydroepiandrosterone (DHEA) Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Dehydroepiandrosterone (DHEA) Revenue Share Forecast by Region (2027-2032)
Table 12. Global Dehydroepiandrosterone (DHEA) Sales by Type (kg) & (2021-2026)
Table 13. Global Dehydroepiandrosterone (DHEA) Sales Share by Type (2021-2026)
Table 14. Global Dehydroepiandrosterone (DHEA) Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Dehydroepiandrosterone (DHEA) Average Price by Type (US$/kg) & (2021-2026)
Table 16. Global Dehydroepiandrosterone (DHEA) Sales by Type (kg) & (2027-2032)
Table 17. Global Dehydroepiandrosterone (DHEA) Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Dehydroepiandrosterone (DHEA) Average Price by Type (US$/kg) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Dehydroepiandrosterone (DHEA) Sales by Application (kg) & (2021-2026)
Table 21. Global Dehydroepiandrosterone (DHEA) Sales Share by Application (2021-2026)
Table 22. Global Dehydroepiandrosterone (DHEA) Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Dehydroepiandrosterone (DHEA) Average Price by Application (US$/kg) & (2021-2026)
Table 24. Global Dehydroepiandrosterone (DHEA) Sales by Application (kg) & (2027-2032)
Table 25. Global Dehydroepiandrosterone (DHEA) Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Dehydroepiandrosterone (DHEA) Average Price by Application (US$/kg) & (2027-2032)
Table 27. New Sources of Growth in Dehydroepiandrosterone (DHEA) Applications
Table 28. Global Dehydroepiandrosterone (DHEA) Sales by Company (kg) & (2021-2026)
Table 29. Global Dehydroepiandrosterone (DHEA) Sales Share by Company (2021-2026)
Table 30. Global Dehydroepiandrosterone (DHEA) Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Dehydroepiandrosterone (DHEA) Revenue Share by Company (2021-2026)
Table 32. Global Dehydroepiandrosterone (DHEA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dehydroepiandrosterone (DHEA) as of 2025)
Table 33. Global Market Dehydroepiandrosterone (DHEA) Average Price by Company (US$/kg) & (2021-2026)
Table 34. Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Product Type & Application
Table 36. Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026) & (kg)
Table 39. North America Dehydroepiandrosterone (DHEA) Sales Market Share by Company (2021-2026)
Table 40. North America Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Dehydroepiandrosterone (DHEA) Revenue Market Share by Company (2021-2026)
Table 42. North America Dehydroepiandrosterone (DHEA) Sales by Type (2021-2026) & (kg)
Table 43. North America Dehydroepiandrosterone (DHEA) Sales Market Share by Type (2021-2026)
Table 44. North America Dehydroepiandrosterone (DHEA) Sales by Application (2021-2026) & (kg)
Table 45. North America Dehydroepiandrosterone (DHEA) Sales Market Share by Application (2021-2026)
Table 46. Europe Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026) & (kg)
Table 47. Europe Dehydroepiandrosterone (DHEA) Sales Market Share by Company (2021-2026)
Table 48. Europe Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Dehydroepiandrosterone (DHEA) Revenue Market Share by Company (2021-2026)
Table 50. Europe Dehydroepiandrosterone (DHEA) Sales by Type (2021-2026) & (kg)
Table 51. Europe Dehydroepiandrosterone (DHEA) Sales Market Share by Type (2021-2026)
Table 52. Europe Dehydroepiandrosterone (DHEA) Sales by Application (2021-2026) & (kg)
Table 53. Europe Dehydroepiandrosterone (DHEA) Sales Market Share by Application (2021-2026)
Table 54. China Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026) & (kg)
Table 55. China Dehydroepiandrosterone (DHEA) Sales Market Share by Company (2021-2026)
Table 56. China Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Dehydroepiandrosterone (DHEA) Revenue Market Share by Company (2021-2026)
Table 58. China Dehydroepiandrosterone (DHEA) Sales by Type (2021-2026) & (kg)
Table 59. China Dehydroepiandrosterone (DHEA) Sales Market Share by Type (2021-2026)
Table 60. China Dehydroepiandrosterone (DHEA) Sales by Application (2021-2026) & (kg)
Table 61. China Dehydroepiandrosterone (DHEA) Sales Market Share by Application (2021-2026)
Table 62. Japan Dehydroepiandrosterone (DHEA) Sales by Company (2021-2026) & (kg)
Table 63. Japan Dehydroepiandrosterone (DHEA) Sales Market Share by Company (2021-2026)
Table 64. Japan Dehydroepiandrosterone (DHEA) Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Dehydroepiandrosterone (DHEA) Revenue Market Share by Company (2021-2026)
Table 66. Japan Dehydroepiandrosterone (DHEA) Sales by Type (2021-2026) & (kg)
Table 67. Japan Dehydroepiandrosterone (DHEA) Sales Market Share by Type (2021-2026)
Table 68. Japan Dehydroepiandrosterone (DHEA) Sales by Application (2021-2026) & (kg)
Table 69. Japan Dehydroepiandrosterone (DHEA) Sales Market Share by Application (2021-2026)
Table 70. Yicheng Goto Pharmaceuticals Co.,Ltd. Company Information
Table 71. Yicheng Goto Pharmaceuticals Co.,Ltd. Description and Business Overview
Table 72. Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 73. Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Product
Table 74. Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Development
Table 75. Junye Pharmaceutical Co., Ltd. Company Information
Table 76. Junye Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 78. Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product
Table 79. Junye Pharmaceutical Co., Ltd. Recent Development
Table 80. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Company Information
Table 81. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 83. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product
Table 84. Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Development
Table 85. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Company Information
Table 86. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 88. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product
Table 89. Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Development
Table 90. Jiangsu Jiaerke Pharmaceuticals Group Corp. Company Information
Table 91. Jiangsu Jiaerke Pharmaceuticals Group Corp. Description and Business Overview
Table 92. Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 93. Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Product
Table 94. Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Development
Table 95. Wudang Antai Pharmaceutical Co., Ltd. Company Information
Table 96. Wudang Antai Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 98. Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product
Table 99. Wudang Antai Pharmaceutical Co., Ltd. Recent Development
Table 100. Shandong Saito Biotechnology Co., Ltd. Company Information
Table 101. Shandong Saito Biotechnology Co., Ltd. Description and Business Overview
Table 102. Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 103. Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Product
Table 104. Shandong Saito Biotechnology Co., Ltd. Recent Development
Table 105. Hubei Dan'ao Pharmaceutical Co., Ltd. Company Information
Table 106. Hubei Dan'ao Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Hubei Dan'ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 108. Hubei Dan'ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product
Table 109. Hubei Dan'ao Pharmaceutical Co., Ltd. Recent Development
Table 110. Symbiotec Pharma Lab Pvt. Ltd. Company Information
Table 111. Symbiotec Pharma Lab Pvt. Ltd. Description and Business Overview
Table 112. Symbiotec Pharma Lab Pvt. Ltd. Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 113. Symbiotec Pharma Lab Pvt. Ltd. Dehydroepiandrosterone (DHEA) Product
Table 114. Symbiotec Pharma Lab Pvt. Ltd. Recent Development
Table 115. NutriScience Innovations, LLC Company Information
Table 116. NutriScience Innovations, LLC Description and Business Overview
Table 117. NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 118. NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Product
Table 119. NutriScience Innovations, LLC Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Dehydroepiandrosterone (DHEA) Distributors List
Table 123. Dehydroepiandrosterone (DHEA) Customers List
Table 124. Dehydroepiandrosterone (DHEA) Market Trends
Table 125. Dehydroepiandrosterone (DHEA) Market Drivers
Table 126. Dehydroepiandrosterone (DHEA) Market Challenges
Table 127. Dehydroepiandrosterone (DHEA) Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Dehydroepiandrosterone (DHEA) Product Picture
Figure 2. Global Dehydroepiandrosterone (DHEA) Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Dehydroepiandrosterone (DHEA) Sales Market Share by Type in 2025 & 2032
Figure 4. ≥ 99％ Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dehydroepiandrosterone (DHEA) Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 7. Global Dehydroepiandrosterone (DHEA) Sales Market Share by Application in 2025 & 2032
Figure 8. Medicine Examples
Figure 9. Dietary Supplements Examples
Figure 10. Skin Care Products Examples
Figure 11. Reagents Examples
Figure 12. Others Examples
Figure 13. Global Dehydroepiandrosterone (DHEA) Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 14. Global Dehydroepiandrosterone (DHEA) Sales Growth Rate (2021-2032) & (US$ Million)
Figure 15. Global Dehydroepiandrosterone (DHEA) Sales (kg) Growth Rate (2021-2032)
Figure 16. Global Dehydroepiandrosterone (DHEA) Price Trends Growth Rate (2021-2032) & (US$/kg)
Figure 17. Dehydroepiandrosterone (DHEA) Report Years Considered
Figure 18. Global Market Dehydroepiandrosterone (DHEA) Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 19. Global Dehydroepiandrosterone (DHEA) Revenue Market Share by Region: 2021 VS 2025
Figure 20. North America Dehydroepiandrosterone (DHEA) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. North America Dehydroepiandrosterone (DHEA) Sales (kg) Growth Rate (2021-2032)
Figure 22. Europe Dehydroepiandrosterone (DHEA) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. Europe Dehydroepiandrosterone (DHEA) Sales (kg) Growth Rate (2021-2032)
Figure 24. China Dehydroepiandrosterone (DHEA) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. China Dehydroepiandrosterone (DHEA) Sales (kg) Growth Rate (2021-2032)
Figure 26. Japan Dehydroepiandrosterone (DHEA) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 27. Japan Dehydroepiandrosterone (DHEA) Sales (kg) Growth Rate (2021-2032)
Figure 28. Global Dehydroepiandrosterone (DHEA) Revenue Share by Type (2021-2026)
Figure 29. Global Dehydroepiandrosterone (DHEA) Sales Share by Type (2027-2032)
Figure 30. Global Dehydroepiandrosterone (DHEA) Revenue Share by Type (2027-2032)
Figure 31. Global Dehydroepiandrosterone (DHEA) Revenue Share by Application (2021-2026)
Figure 32. Global Dehydroepiandrosterone (DHEA) Revenue Market Share by Application in 2021 & 2025
Figure 33. Global Dehydroepiandrosterone (DHEA) Sales Share by Application (2027-2032)
Figure 34. Global Dehydroepiandrosterone (DHEA) Revenue Share by Application (2027-2032)
Figure 35. Global Dehydroepiandrosterone (DHEA) Sales Share by Company (2025)
Figure 36. Global Dehydroepiandrosterone (DHEA) Revenue Share by Company (2025)
Figure 37. Global 5 Largest Dehydroepiandrosterone (DHEA) Players Market Share by Revenue in Dehydroepiandrosterone (DHEA): 2021 & 2025
Figure 38. Dehydroepiandrosterone (DHEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 39. Manufacturing Cost Structure of Dehydroepiandrosterone (DHEA)
Figure 40. Manufacturing Process Analysis of Dehydroepiandrosterone (DHEA)
Figure 41. Dehydroepiandrosterone (DHEA) Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Dehydroepiandrosterone (DHEA) in 2032?
The global market size of Dehydroepiandrosterone (DHEA) in 2032 was 81.63 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Dehydroepiandrosterone (DHEA) in 2026?
What is the annual compound growth rate of the global Dehydroepiandrosterone (DHEA) market size from 2026 to 2032?
Which companies rank high in the global Dehydroepiandrosterone (DHEA) market?
Related Reports
Global Dehydroepiandrosterone (DHEA) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 50.97 million in 2025 to US$ 81.63 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 135
USD 4900.00
(Single User License)
Dehydroepiandrosterone (DHEA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 50.97 million in 2025 and is projected to reach US$ 81.63 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 106
USD 3950.00
(Single User License)
Global Dehydroepiandrosterone (DHEA) Market Research Report 2026
The global Dehydroepiandrosterone (DHEA) market was valued at US$ 50.97 million in 2025 and is anticipated to reach US$ 81.63 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 127
USD 2900.00
(Single User License)
Global Dehydroepiandrosterone (DHEA) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 49 million in 2024 to US$ 76.7 million by 2031, at a CAGR of 7.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 143
USD 4900.00
(Single User License)
Dehydroepiandrosterone (DHEA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-03-26
Pages: 98
USD 3950.00
(Single User License)
Global Dehydroepiandrosterone (DHEA) Market Insights, Forecast to 2031
Valued at US$ 51 million in 2024, the global Dehydroepiandrosterone (DHEA) market is forecast to reach US$ 76.7 million by 2030, at a CAGR of 7.1% during the forecast period.
Published Date: 2025-03-26
Pages: 149
USD 4900.00
(Single User License)
Global Dehydroepiandrosterone (DHEA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dehydroepiandrosterone (DHEA) market size was US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-03-26
Pages: 79
USD 4250.00
(Single User License)
Global Dehydroepiandrosterone (DHEA) Market Research Report 2025
The global market for Dehydroepiandrosterone (DHEA) was valued at US$ 49 million in the year 2024 and is projected to reach a revised size of US$ 76.7 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published Date: 2025-03-26
Pages: 90
USD 2900.00
(Single User License)
Dehydroepiandrosterone (DHEA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 48.9 million in 2024 and is forecast to a readjusted size of US$ 66.8 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 101
USD 3950.00
(Single User License)
Global Dehydroepiandrosterone (DHEA) Market Insights, Forecast to 2030
Dehydroepiandrosterone is a precursor hormone, which means it has little biological effect on its own, but has powerful effects when converted into other hormones such as testosterone and oestradiol.
Published Date: 2024-04-22
Pages: 86
USD 4900.00
(Single User License)
Global Dehydroepiandrosterone (DHEA) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 50.97 million in 2025 to US$ 81.63 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 135
USD 4900.00 (Single User License)Dehydroepiandrosterone (DHEA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 50.97 million in 2025 and is projected to reach US$ 81.63 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 106
USD 3950.00 (Single User License)Global Dehydroepiandrosterone (DHEA) Market Research Report 2026
The global Dehydroepiandrosterone (DHEA) market was valued at US$ 50.97 million in 2025 and is anticipated to reach US$ 81.63 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 127
USD 2900.00 (Single User License)Global Dehydroepiandrosterone (DHEA) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 49 million in 2024 to US$ 76.7 million by 2031, at a CAGR of 7.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 143
USD 4900.00 (Single User License)Dehydroepiandrosterone (DHEA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-03-26
Pages: 98
USD 3950.00 (Single User License)Global Dehydroepiandrosterone (DHEA) Market Insights, Forecast to 2031
Valued at US$ 51 million in 2024, the global Dehydroepiandrosterone (DHEA) market is forecast to reach US$ 76.7 million by 2030, at a CAGR of 7.1% during the forecast period.
Published: 2025-03-26
Pages: 149
USD 4900.00 (Single User License)Global Dehydroepiandrosterone (DHEA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dehydroepiandrosterone (DHEA) market size was US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-03-26
Pages: 79
USD 4250.00 (Single User License)Global Dehydroepiandrosterone (DHEA) Market Research Report 2025
The global market for Dehydroepiandrosterone (DHEA) was valued at US$ 49 million in the year 2024 and is projected to reach a revised size of US$ 76.7 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published: 2025-03-26
Pages: 90
USD 2900.00 (Single User License)Dehydroepiandrosterone (DHEA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 48.9 million in 2024 and is forecast to a readjusted size of US$ 66.8 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 101
USD 3950.00 (Single User License)Global Dehydroepiandrosterone (DHEA) Market Insights, Forecast to 2030
Dehydroepiandrosterone is a precursor hormone, which means it has little biological effect on its own, but has powerful effects when converted into other hormones such as testosterone and oestradiol.
Published: 2024-04-22
Pages: 86
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now